Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ZTS Relative to the S&P 500

ZTS Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Zoetis Inc. (NYSE:ZTS) seasonal charts above shows that a Buy Date of April 4 and a Sell Date of August 10 has resulted in a geometric average return of 5.32% above the benchmark rate of the S&P 500 Total Return Index over the past 13 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is an excellent rate of success and the return outperforms the relative buy-and-hold performance of the stock over the past 13 years by an average of 1.76% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer’s animal health unit.

To download ZTS seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ZTS